Antifungal Agents Flashcards
Compared to bacteria, fungi have
Different ribosomes
Different cell wall components (chitin, mannoproteins and glucans)
A nuclear membrane
Control of mycotic infections
Immunization is not usually effective
Control involves IV amphotericin B, flucytosine, azoles and nystatin
In some cases surgical removal of damaged tissue
Prevention limited to masks and protective clothing to reduce contact with spores
Except for _________________ and _________________, all currently available antifungals target the cell membrane
Flucytosine; griseofulvin
Azoles
Interfere with ergosterol synthesis by targeting lanosterol demethylase enzyme, leading to defective cell membranes through accumulation of toxic sterol products; used to treat a variety of systemic and localized fungal infections
All are synthetic, show broad activity towards years and molds (no antibacterial action), orally active or topical, and fungistatic or fungicidal
Imidazoles - ketoconazole, miconazole and clotrimazole
Triazoles - fluconazole and itraconazole
Imadazoles
COMET - K
Clotrimazole Oxiconazole Miconazole Econazole Tioconazole Ketoconazole
Triazoles
FIT VIP
Fluconazole Itraconazole Terconazole Voriconazole Isavuconazole Posaconazole
Echinocandins
MAC
Micafungin
Anidulafungin
Caspofungin
Allylamines
ANT
Amorolfin
Naftifine
Terbinafine
Clotrimazole
Topical imidazole (cream, ear drops) - OTC
Troche - throat lozenge
Treats vaginal yeast, ringworm, athlete’s foot, jock itch and thrush
Side effects include skin irritation, rash, hives, burning, itching, redness, est.
Ketoconazole
Imidazole
Tablet, cream, shampoo
Oral administration, requires low pH for absorption
Numerous dose-limiting side effects: hepatotoxic, teratogenic, GI disturbances, disruption of mammalian steroid hormone biosynthesis
Largely replaced by the newer triazoles
Fluconazole
Oral or IV Triazole - good absorption and distribution; also for topical use
Oral and esophageal candidiasis in AIDS patients
Cryptococcal meningitis
Better tolerated than ketoconazole
Resistance is common, but usually limited to AIDs patients and after long-term therapy
Potential adverse effects: rash, nausea, hepatotoxicity
Itraconazole
Oral Triazole
Similar to ketoconazole in structure but can’t form the same toxic metabolites
Better specificity for fungal cyp450, decreasing toxicity
Broader spectrum than fluconazole, but not as well tolerated as fluconazole
Often drug of choice for non-life-threating mycoses
99% protein bound; no cerebrospinal fluid penetration
Many potential side effects
New Generation Triazoles
Some have excellent in vitro activity against a wide variety of fungal pathogens
MIC values lower against most Candid spp.
Have in vitro activity against Aspergillus sp. that is comparable or better than that of amphotericin B and itraconazole
Voriconazole, Posaconazole
Voriconazole
New generation triazoles
Approved for acute invasive aspergillosis and salvage therapy for several other rare mycoses
Outperformed amphotericin B in trials
IV or oral
Side effects include visual disturbances and increased liver enzymes
Posaconazole
New generation triazole
Similar to itraconazole but better activity and broader spectrum; may cause more serious side effects
Side effects include fever, diarrhea, nausea, increased liver enzymes
Oral only; slow absorption (3-5 hours) and has a long half life (35 hours)
Used to treat invasive infection of Candida, Mucor, and Aspergillus in immunocompromised patients